A Single-site, Open-label, Fixed-sequence Phase 1 Study Evaluating the Effect of Eliglustat (Genz-112638) on the Pharmacokinetics and Safety and Tolerability of Digoxin in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Digoxin (Primary) ; Eliglustat (Primary)
- Indications Arrhythmias; Lysosomal storage diseases
- Focus Pharmacokinetics
- Sponsors Genzyme Corporation
- 07 Jun 2017 Biomarkers information updated
- 06 Apr 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 06 Apr 2012 Actual initiation date changed from May 2011 to Aug 2011 as reported by ClinicalTrials.gov.